FDAFDA · Food and drugs·Recall number D-0444-2024
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
Published April 24, 2024 · Recall initiated: March 28, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- AvKARE
- Distributor
- US Nationwide.
- Lot
- Lot: AW0221A Exp. 08/30/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.